DE3685170D1 - Histaminderivate enthaltende pharmazeutische zusammensetzung. - Google Patents

Histaminderivate enthaltende pharmazeutische zusammensetzung.

Info

Publication number
DE3685170D1
DE3685170D1 DE8686401917T DE3685170T DE3685170D1 DE 3685170 D1 DE3685170 D1 DE 3685170D1 DE 8686401917 T DE8686401917 T DE 8686401917T DE 3685170 T DE3685170 T DE 3685170T DE 3685170 D1 DE3685170 D1 DE 3685170D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition containing
containing histamine
histamine derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686401917T
Other languages
English (en)
Inventor
Jean-Michel Batiment Arrang
Monique Garbarg
Walter Frei Univ Berl Schunack
Jean-Charles Schwartz
Ralph Ortwin Institut Fue Lipp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE3685170D1 publication Critical patent/DE3685170D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8686401917T 1985-09-02 1986-09-01 Histaminderivate enthaltende pharmazeutische zusammensetzung. Expired - Lifetime DE3685170D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8513024A FR2586562B1 (fr) 1985-09-02 1985-09-02 Composition pharmaceutique contenant de l'a-methylhistamine

Publications (1)

Publication Number Publication Date
DE3685170D1 true DE3685170D1 (de) 1992-06-11

Family

ID=9322551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686401917T Expired - Lifetime DE3685170D1 (de) 1985-09-02 1986-09-01 Histaminderivate enthaltende pharmazeutische zusammensetzung.

Country Status (5)

Country Link
US (1) US4767778A (de)
EP (1) EP0214058B1 (de)
JP (1) JPH0788303B2 (de)
DE (1) DE3685170D1 (de)
FR (1) FR2586562B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2630328B1 (fr) * 1988-04-22 1990-08-24 Inst Nat Sante Rech Med Derive de l'histamine, sa preparation et son application en therapeutique
FR2661909B1 (fr) * 1990-05-09 1997-08-14 Inst Nat Sante Rech Med Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.
US5162541A (en) * 1990-09-10 1992-11-10 Schering Corporation Transfer hydrogenolysis of alkylheteroaryl halo-containing compounds
US5821259A (en) * 1991-11-12 1998-10-13 Theoharides; Theoharis C. H3 -receptor agonists as therapeutic agents
DE69205287T2 (de) * 1991-12-18 1996-03-14 Schering Corp Imidazolylalkyl- piperazin und -diazepin derivate als histamin h3 agonisten/antagonisten.
US5932596A (en) * 1991-12-18 1999-08-03 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing nitrogen containing heterocyclic ring
ES2089782T3 (es) * 1991-12-18 1996-10-01 Schering Corp Imidazolalquilo sustituido con un anillo heterociclico que contiene nitrogeno de seis elementos.
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
MY110108A (en) * 1991-12-18 1998-01-27 Schering Corp Imidazolyl or imidazolylalkyl substituted with a four or five membered nitrigen containing heterocyclic ring
US5633250A (en) * 1991-12-18 1997-05-27 Schering Corporation Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
US5639775A (en) * 1992-04-01 1997-06-17 The University Of Toledo 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
CA2133461A1 (en) * 1992-04-01 1993-10-14 Graham J. Durant 4-[4'piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
US5486526A (en) * 1992-04-01 1996-01-23 The University Of Toledo Histamine H3 -receptor antagonists and therapeutic uses thereof
DK0841923T3 (da) * 1995-06-07 2003-01-27 Gliatech Inc 1H-4(5)-substituerede imidazolderivater
US6072057A (en) * 1996-06-06 2000-06-06 Gliatech Inc. 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
US7906153B2 (en) * 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
JP2002534511A (ja) 1999-01-18 2002-10-15 ノボ ノルディスク アクティーゼルスカブ 置換型イミダゾール、それらの調製及び使用
US6211182B1 (en) 1999-03-08 2001-04-03 Schering Corporation Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
GB9924941D0 (en) * 1999-10-22 1999-12-22 Univ Manchester Treatment of dyskinesia
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
US6794405B2 (en) 2000-08-17 2004-09-21 Merck & Co., Inc. Alicyclic imidazoles as H3 agents
MY129677A (en) 2000-09-20 2007-04-30 Schering Corp Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
ATE283853T1 (de) * 2000-09-20 2004-12-15 Schering Corp Substituierte imidazole als duale histamine h1 und h3 agonisten oder antagonisten
EP1318993B1 (de) 2000-09-20 2008-08-20 Schering Corporation Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten
DE60133014T2 (de) 2000-09-20 2009-02-26 Schering Corp. Substituierte imidazole als duale histamin h1 und h3 agonisten oder antagonisten
AU2003227358A1 (en) * 2002-04-24 2003-11-10 Banyu Pharmaceutical Co., Ltd. Histamine receptor h3 ordinary activity mutant and utilization thereof
KR100925900B1 (ko) 2005-04-28 2009-11-09 화이자 리미티드 아미노산 유도체
ES2369682B1 (es) * 2009-11-26 2012-10-15 Universitat Autónoma De Barcelona Uso de agonistas histaminérgicos h3 en el tratamiento de la adicción a drogas de abuso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1192954A (en) * 1967-09-15 1970-05-28 Philippe Serviere Tartaric Acid-Histidine Salts
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
US4100349A (en) * 1977-07-01 1978-07-11 Brian Walter Metcalf α-Acetylenic derivatives of histamine and related compounds

Also Published As

Publication number Publication date
FR2586562B1 (fr) 1989-03-10
EP0214058B1 (de) 1992-05-06
EP0214058A3 (en) 1989-11-29
JPH0788303B2 (ja) 1995-09-27
US4767778A (en) 1988-08-30
EP0214058A2 (de) 1987-03-11
JPS62123174A (ja) 1987-06-04
FR2586562A1 (fr) 1987-03-06

Similar Documents

Publication Publication Date Title
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
NO863029D0 (no) Farmasoeytisk doseringsenhet.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3576117D1 (de) Mehrphasige pharmazeutische zusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872733A (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1213453B (it) Composizione farmaceutica.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3873011D1 (de) Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate.
ES297038Y (es) Tableta farmaceutica.
ATA133288A (de) Pharmazeutische zusammensetzung
DE68907609T2 (de) Arzneimittelzusammensetzung.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
DE68902056T2 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
IT8520591A0 (it) Formulazione farmaceutica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition